Project Details
Description
Cancer is the commonest disease causing death in children. New anticancer drugs are developed against one adult cancer gene target. Anticancer drugs work best in combination to overcome resistance. Our network of scientists and doctors have developed a diagnostic platform to better match the drug to the gene target for high risk child cancer. We will develop effective child cancer-specific combination therapy, accurate diagnostics for resistance and integrate consumers in the research pathway.
Status | Finished |
---|---|
Effective start/end date | 9/1/20 → 5/31/23 |
Funding
- National Science Foundation: $10,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.